Early Economic Evaluation
Cross-source consensus on Early Economic Evaluation from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Dosage & preparation
Comparisons
Evidence quality
Highlighted claims
- Sensitivity analyses test insomnia remission scenarios of 25%, 50%, 75%, and 100% to capture uncertainty in treatment effectiveness. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
- The model applies a one-year time horizon for intervention costs and a 0% discount rate because the treatment cycle takes under one year. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
- The early HTA framework allows stakeholders to gauge economic value before full randomised controlled trial data are available, potentially shortening the path to implementation. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
- The model conservatively excludes disability pension, presenteeism, and post-acute coronary syndrome sick leave costs, all of which would increase the magnitude of projected savings. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
- DRG-based cost estimates used in the model are internally valid for the Norwegian setting but have limited generalisability to other health systems. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
- Productivity loss in the model is calculated using a conservative human capital approach that accounts for task transfers and overtime, likely underestimating true savings. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation